A phase lb study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

被引：1
|
作者：
Weekes, Colin
Lockhart, A. Craig
Lenz, Heinz-Josef
Lee, James J.
Cleton, Adriaan
Huang, Funan
Sturm, Isrid
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-CT148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT148
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Phase I study of safety, tolerability, and pharmacokinetics of pazopanib in combination with oral topotecan in patients with advanced solid tumors
    Kerklaan, Bojana Milojkovic
    Lolkema, Martijn P. J. K.
    Devriese, Lot A.
    Voest, Emile E.
    Nol-Boekel, A.
    Mergui-Roelvink, M.
    Mykulowycz, Kristine
    Stoebenau, Joseph E.
    Fang, Lei
    Legenne, Philippe
    Wissel, Paul Stephen
    Smith, Deborah A.
    Giantonio, Bruce J.
    Schellens, Jan H. M.
    Witteveen, Petronella
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [12] Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors
    William F. Maguire
    John C. Schmitz
    Jonas Scemama
    Ken Czambel
    Yan Lin
    Anthony G. Green
    Shaoyu Wu
    Huang Lin
    Shannon Puhalla
    John Rhee
    Ronald Stoller
    Hussein Tawbi
    James J. Lee
    John J. Wright
    Jan H. Beumer
    Edward Chu
    Leonard J. Appleman
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 643 - 654
  • [13] Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study
    Hidenori Kato
    Paul de Souza
    Sang-We Kim
    Jason D. Lickliter
    Yoichi Naito
    Keunchil Park
    Sanjeev Kumar
    Ganesh M. Mugundu
    Yung-Jue Bang
    Targeted Oncology, 2020, 15 : 75 - 84
  • [14] A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Leong, Stephen
    Moss, Rebecca A.
    Bowles, Daniel W.
    Ware, Joseph A.
    Zhou, Jing
    Spoerke, Jill M.
    Lackner, Mark R.
    Shankar, Geetha
    Schutzman, Jennifer L.
    van der Noll, Ruud
    Voest, Emile E.
    Schellens, Jan H. M.
    ONCOLOGIST, 2017, 22 (12): : 1491 - 1499
  • [15] Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study
    Kato, Hidenori
    de Souza, Paul
    Kim, Sang-We
    Lickliter, Jason D.
    Naito, Yoichi
    Park, Keunchil
    Kumar, Sanjeev
    Mugundu, Ganesh M.
    Bang, Yung-Jue
    TARGETED ONCOLOGY, 2020, 15 (01) : 75 - 84
  • [16] Phase I study of combination treatment with PTK 787/ZK 222584 (PTK/ZK) and cetuximab for patients with advanced solid tumors: Safety, pharmacokinetics, pharmacodynamics, and toxicity analysis
    Langenberg, M. H.
    Witteveen, P. O.
    Lankheet, N.
    Roodhart, J. M.
    Rosing, H.
    Beijnen, J. H.
    Voest, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [17] A phase I study of E7820 in combination with Cetuximab in patients (pts) with advanced solid tumors
    El-Khoueiry, A. B.
    Iqbal, S.
    Feit, K.
    Lenz, H. J.
    Okereke, C.
    Krivelevich, I.
    Goldberg, T.
    Conti, P.
    Rossignol, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [18] Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
    Soria, J. -C.
    DeBraud, F.
    Bahleda, R.
    Adamo, B.
    Andre, F.
    Dientsmann, R.
    Delmonte, A.
    Cereda, R.
    Isaacson, J.
    Litten, J.
    Allen, A.
    Dubois, F.
    Saba, C.
    Robert, R.
    D'Incalci, M.
    Zucchetti, M.
    Camboni, M. G.
    Tabernero, J.
    ANNALS OF ONCOLOGY, 2014, 25 (11) : 2244 - 2251
  • [19] A phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
    Soria, Jean-Charles
    De Braud, Filippo G.
    Bahleda, Ratislav
    Adamo, Barbara
    Cereda, Roberta
    Camboni, Maria Gabriella
    Robert, Renate
    Isaacson, Jeffrey D.
    Litten, Jason B.
    Allen, Andrew R.
    Rolfe, Lindsey
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [20] Pharmacokinetics and safety of sorafenib in combination with capecitabine in advanced solid tumors
    Infante, Jeffrey R.
    Jones, Suzanne F.
    Bendell, Johanna C.
    Greco, F. Anthony
    Yardley, Denise A.
    Woudenberg, Janet
    Lathia, Chetan D.
    Lane, Cassie M.
    Spigel, David R.
    Hainsworth, John D.
    Burns, Howard A., III
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
12345